Expression of heme oxygenase-1 in neural stem/progenitor cells as a potential mechanism to evade host immune response

Stem Cells

Volumn 30, Issue 10, 2012, Pages 2342-2353

  Bonnamain, Virginie ^a,b,c   Mathieux, Elodie ^a,b,c   Thinard, Reynald ^a,b,c   Thébault, Paméla ^a,b,c   Nerrière Daguin, Véronique ^a,b,c   Lévêque, Xavier ^a,b,c   Anegon, Ignacio ^a,b,c   Vanhove, Bernard ^a,b   Neveu, Isabelle ^a,b,c   Naveilhan, Philippe ^a,b,c  

^a INSERM   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE NANTES   (France)

Author keywords

Heme oxygenase 1; Immune properties; Immunomodulation; Nitric oxide synthase; Stem cells; T cells; Transplantation

Indexed keywords

GAMMA INTERFERON; HEME OXYGENASE 1; INTERLEUKIN 2; TRANSCRIPTION FACTOR FOXP3;

AMPLICON; ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; BRAIN; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; EMBRYO; FETUS; FLOW CYTOMETRY; IMMUNE RESPONSE; INHIBITION KINETICS; LYMPHOCYTE PROLIFERATION; MOLECULAR INTERACTION; NATURAL KILLER CELL; NEURAL STEM CELL; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; RAT; RECEPTOR AFFINITY; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; BRAIN; CELL COMMUNICATION; CELL PROLIFERATION; COCULTURE TECHNIQUES; EMBRYO, MAMMALIAN; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HEME OXYGENASE-1; IMMUNITY, INNATE; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; NEURAL STEM CELLS; NITRIC OXIDE SYNTHASE; PRIMARY CELL CULTURE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES, REGULATORY;

RATTUS;

EID: 84866645333     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1199     Document Type: Article

References (60)

1. Hori J, Ng TF, Shatos M et al. Neural progenitor cells lack immunogenicity and resist destruction as allografts. Stem Cells 2003;21:405-416.
2. Armstrong RJ, Harrower TP, Hurelbrink CB et al. Porcine neural xenografts in the immunocompetent rat: Immune response following grafting of expanded neural precursor cells. Neuroscience 2001;106:201-216.
3. Michel-Monigadon D, Bonnamain V, Nerriere-Daguin V et al. Trophic and immunoregulatory properties of neural precursor cells: Benefit for intracerebral transplantation. Exp Neurol 2011;230:35-47.
4. Odeberg J, Piao JH, Samuelsson EB et al. Low immunogenicity of in vitro-expanded human neural cells despite high MHC expression. J Neuroimmunol 2005;161:1-11.
5. Bartholomew A, Sturgeon C, Siatskas M et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002;30:42-48.
6. Di Nicola M, Carlo-Stella C, Magni M et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002;99:3838-3843.
7. Chabannes D, Hill M, Merieau E et al. A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood 2007;110:3691-3694.
8. Zappia E, Casazza S, Pedemonte E et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005;106:1755-1761.
9. Einstein O, Karussis D, Grigoriadis N et al. Intraventricular transplantation of neural precursor cell spheres attenuates acute experimental allergic encephalomyelitis. Mol Cell Neurosci 2003;24:1074-1082.
10. Einstein O, Fainstein N, Vaknin I et al. Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression. Ann Neurol 2007;61:209-218.
11. Pluchino S, Zanotti L, Rossi B et al. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 2005;436:266-271.
12. Batten P, Sarathchandra P, Antoniw JW et al. Human mesenchymal stem cells induce T cell anergy and downregulate T cell alloresponses via the TH2 pathway: Relevance to tissue engineering human heart valves. Tissue Eng 2006;12:2263-2273.
13. Groh ME, Maitra B, Szekely E et al. Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp Hematol 2005;33:928-934.
14. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815-1822.
15. Meisel R, Zibert A, Laryea M et al. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004;103:4619-4621.
16. Sato K, Ozaki K, Oh I et al. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 2007;109:228-234.
17. Ren G, Zhang L, Zhao X et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2008;2:141-150.
18. Sergent-Tanguy S, Veziers J, Bonnamain V et al. Cell surface antigens on rat neural progenitors and characterization of the CD3 (+)/CD3 (-) cell populations. Differentiation 2006;74:530-541.
19. Bonnamain V, Neveu I, Naveilhan P. In vitro analyses of the immunosuppressive properties of neural stem/progenitor cells using anti-CD3/CD28-activated T cells. Methods Mol Biol 2011;677:233-243.
20. Dugast AS, Haudebourg T, Coulon F et al. Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion. J Immunol 2008;180:7898-7906.
21. David A, Coupel-Clauce H, Chetritt J et al. Anti-adenovirus immune responses in rats are enhanced by interleukin 4 but not interleukin 10 produced by recombinant adenovirus. Hum Gene Ther 1998;9:1755-1768.
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-408.
23. Wheway J, Herzog H, Mackay F. NPY and receptors in immune and inflammatory diseases. Curr Top Med Chem 2007;7:1743-1752.
24. Kappas A, Drummond GS. Control of heme metabolism with synthetic metalloporphyrins. J Clin Invest 1986;77:335-339.
25. Pluchino S, Quattrini A, Brambilla E et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 2003;422:688-694.
26. Ramasamy R, Tong CK, Seow HF et al. The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function. Cell Immunol 2008;251:131-136.
27. Casiraghi F, Azzollini N, Cassis P et al. Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J Immunol 2008;181:3933-3946.
28. Maccario R, Podesta M, Moretta A et al. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica 2005;90:516-525.
29. Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007;110:3499-3506.
30. Klassen HJ, Imfeld KL, Kirov II et al. Expression of cytokines by multipotent neural progenitor cells. Cytokine 2003;22:101-106.
31. Kehrl JH, Wakefield LM, Roberts AB et al. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986;163:1037-1050.
32. Bedoui S, Miyake S, Lin Y et al. Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo. J Immunol 2003;171:3451-3458.
33. Wheway J, Herzog H, Mackay F. The Y1 receptor for NPY: A key modulator of the adaptive immune system. Peptides 2007;28:453-458.
34. Jones BJ, Brooke G, Atkinson K et al. Immunosuppression by placental indoleamine 2,3-dioxygenase: A role for mesenchymal stem cells. Placenta 2007;28:1174-1181.
35. Wang L, Shi J, van Ginkel FW et al. Neural stem/progenitor cells modulate immune responses by suppressing T lymphocytes with nitric oxide and prostaglandin E2. Exp Neurol 2009;216:177-183.
36. Willis D, Moore AR, Frederick R et al. Heme oxygenase: A novel target for the modulation of the inflammatory response. Nat Med 1996;2:87-90.
37. Sato K, Balla J, Otterbein L et al. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 2001;166:4185-4194.
38. Soares MP, Bach FH. Heme oxygenase-1 in organ transplantation. Front Biosci 2007;12:4932-4945.
39. Soares MP, Lin Y, Anrather J et al. Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 1998;4:1073-1077.
40. Bouchet D, Chauveau C, Roussel JC et al. Inhibition of graft arteriosclerosis development in rat aortas following heme oxygenase-1 gene transfer. Transpl Immunol 2002;9:235-238.
41. Braudeau C, Bouchet D, Tesson L et al. Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer. Gene Ther 2004;11:701-710.
42. Moreau A, Hill M, Thebault P et al. Tolerogenic dendritic cells actively inhibit T cells through heme oxygenase-1 in rodents and in nonhuman primates. FASEB J 2009;23:3070-3077.
43. Pae HO, Oh GS, Choi BM et al. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol 2004;172:4744-4751.
44. Song R, Mahidhara RS, Zhou Z et al. Carbon monoxide inhibits T lymphocyte proliferation via caspase-dependent pathway. J Immunol 2004;172:1220-1226.
45. Yamashita K, McDaid J, Ollinger R et al. Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allografts. FASEB J 2004;18:765-767.
46. Haga Y, Tempero MA, Zetterman RK. Unconjugated bilirubin inhibits in vitro cytotoxic T lymphocyte activity of human lymphocytes. Biochim Biophys Acta 1996;1317:65-70.
47. Albina JE, Abate JA, Henry WL, Jr. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. Role of IFN-gamma in the induction of the nitric oxide-synthesizing pathway. J Immunol 1991;147:144-148.
48. Bingisser RM, Tilbrook PA, Holt PG et al. Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway. J Immunol 1998;160:5729-5734.
49. Colasanti M, Persichini T, Menegazzi M et al. Induction of nitric oxide synthase mRNA expression. Suppression by exogenous nitric oxide. J Biol Chem 1995;270:26731-26733.
50. Togashi H, Sasaki M, Frohman E et al. Neuronal (type I) nitric oxide synthase regulates nuclear factor kappaB activity and immunologic (type II) nitric oxide synthase expression. Proc Natl Acad Sci USA 1997;94:2676-2680.
51. Perez-Rodriguez R, Roncero C, Olivan AM et al. Signaling mechanisms of interferon gamma induced apoptosis in chromaffin cells: Involvement of nNOS, iNOS, and NFkappaB. J Neurochem 2009;108:1083-1096.
52. Hartsfield CL. Cross talk between carbon monoxide and nitric oxide. Antioxid Redox Signal 2002;4:301-307.
53. Hartsfield CL, Alam J, Cook JL et al. Regulation of heme oxygenase-1 gene expression in vascular smooth muscle cells by nitric oxide. Am J Physiol 1997;273:L980-988.
54. Polte T, Abate A, Dennery PA et al. Heme oxygenase-1 is a cGMP-inducible endothelial protein and mediates the cytoprotective action of nitric oxide. Arterioscler Thromb Vasc Biol 2000;20:1209-1215.
55. Durante W, Kroll MH, Christodoulides N et al. Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ Res 1997;80:557-564.
56. Bonnamain V, Neveu I, Naveilhan P. Neural stem/progenitor cells as a promising candidate for regenerative therapy of the central nervous system. Front Cell Neurosci 2012;6:17.
57. Trigona WL, Porter CM, Horvath-Arcidiacono JA et al. Could hemeoxygenase-1 have a role in modulating the recipient immune response to embryonic stem cells? Antioxid Redox Signal 2007;9:751-756.
58. Fandrich F, Lin X, Chai GX et al. Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nat Med 2002;8:171-178.
59. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008;8:726-736.
60. Krystkowiak P, Gaura V, Labalette M et al. Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease. PLoS One 2007;2:e166.